Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients

Tae Jun Kim, Ja Seol Koo, Sung Jin Kim, Sung Noh Hong, You Sun Kim, Suk Kyun Yang, Young Ho Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and aim: Altered gene expression in intestinal mucosa is thought to contribute to inflammatory process in Crohn’s disease (CD). The present study investigated changes in the expression of genes associated with gut inflammation in CD patients by RNA microarray to identify disease biomarkers. Methods: Microarray analysis was carried out in formalin-fixed, paraffin-embedded intestinal tissue specimens from six CD patients who underwent surgery without prior treatment and from two healthy control subjects. Transcripts overexpressed in CD patients were validated by enzyme-linked immunosorbent assay (ELISA) using specimens from 46 CD patients and 60 healthy controls. Results: Among the genes over-expressed with statistical significance, five genes including decay-accelerating factor, interleukin-1 receptor (IL1R) A, tumour necrosis factor receptor 2, (C-X-C motif) ligand (CXCL) 1, and granzyme (GZM) B proposed to have functional association with CD were selected to validate the expressed transcripts in serum. Serum concentration of IL1RA, CXCL1, and GZMB measured by ELISA were significantly higher in CD patients. Conclusions: We identified that IL1RA, CXCL1, and GZMB are overexpressed in CD patients. Serum IL1RA and GZMB levels were markedly increased in CD patients, suggesting that these markers can serve as biomarkers to identify gut inflammation. Further studies will be required to evaluate this possibility.

Original languageEnglish
Pages (from-to)161-166
Number of pages6
JournalBiomarkers
Volume23
Issue number2
DOIs
Publication statusPublished - 2018 Feb 17

Fingerprint

Interleukin 1 Receptor Antagonist Protein
Granzymes
Biomarkers
Crohn Disease
Immunosorbents
Genes
Microarrays
Assays
Serum
Enzyme-Linked Immunosorbent Assay
CD55 Antigens
Receptors, Tumor Necrosis Factor, Type II
Inflammation
Gene Expression
Interleukin-1 Receptors
Intestinal Mucosa
Microarray Analysis
Enzymes
Paraffin
Formaldehyde

Keywords

  • biomarker
  • Crohn’s disease
  • inflammatory bowel disease
  • RNA microarray
  • transcripts

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

Kim, T. J., Koo, J. S., Kim, S. J., Hong, S. N., Kim, Y. S., Yang, S. K., & Kim, Y. H. (2018). Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients. Biomarkers, 23(2), 161-166. https://doi.org/10.1080/1354750X.2017.1387933

Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients. / Kim, Tae Jun; Koo, Ja Seol; Kim, Sung Jin; Hong, Sung Noh; Kim, You Sun; Yang, Suk Kyun; Kim, Young Ho.

In: Biomarkers, Vol. 23, No. 2, 17.02.2018, p. 161-166.

Research output: Contribution to journalArticle

Kim, TJ, Koo, JS, Kim, SJ, Hong, SN, Kim, YS, Yang, SK & Kim, YH 2018, 'Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients', Biomarkers, vol. 23, no. 2, pp. 161-166. https://doi.org/10.1080/1354750X.2017.1387933
Kim, Tae Jun ; Koo, Ja Seol ; Kim, Sung Jin ; Hong, Sung Noh ; Kim, You Sun ; Yang, Suk Kyun ; Kim, Young Ho. / Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients. In: Biomarkers. 2018 ; Vol. 23, No. 2. pp. 161-166.
@article{fed2963e058947fc8ea9b66314da8e33,
title = "Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients",
abstract = "Background and aim: Altered gene expression in intestinal mucosa is thought to contribute to inflammatory process in Crohn’s disease (CD). The present study investigated changes in the expression of genes associated with gut inflammation in CD patients by RNA microarray to identify disease biomarkers. Methods: Microarray analysis was carried out in formalin-fixed, paraffin-embedded intestinal tissue specimens from six CD patients who underwent surgery without prior treatment and from two healthy control subjects. Transcripts overexpressed in CD patients were validated by enzyme-linked immunosorbent assay (ELISA) using specimens from 46 CD patients and 60 healthy controls. Results: Among the genes over-expressed with statistical significance, five genes including decay-accelerating factor, interleukin-1 receptor (IL1R) A, tumour necrosis factor receptor 2, (C-X-C motif) ligand (CXCL) 1, and granzyme (GZM) B proposed to have functional association with CD were selected to validate the expressed transcripts in serum. Serum concentration of IL1RA, CXCL1, and GZMB measured by ELISA were significantly higher in CD patients. Conclusions: We identified that IL1RA, CXCL1, and GZMB are overexpressed in CD patients. Serum IL1RA and GZMB levels were markedly increased in CD patients, suggesting that these markers can serve as biomarkers to identify gut inflammation. Further studies will be required to evaluate this possibility.",
keywords = "biomarker, Crohn’s disease, inflammatory bowel disease, RNA microarray, transcripts",
author = "Kim, {Tae Jun} and Koo, {Ja Seol} and Kim, {Sung Jin} and Hong, {Sung Noh} and Kim, {You Sun} and Yang, {Suk Kyun} and Kim, {Young Ho}",
year = "2018",
month = "2",
day = "17",
doi = "10.1080/1354750X.2017.1387933",
language = "English",
volume = "23",
pages = "161--166",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Role of IL-1ra and Granzyme B as biomarkers in active Crohn’s disease patients

AU - Kim, Tae Jun

AU - Koo, Ja Seol

AU - Kim, Sung Jin

AU - Hong, Sung Noh

AU - Kim, You Sun

AU - Yang, Suk Kyun

AU - Kim, Young Ho

PY - 2018/2/17

Y1 - 2018/2/17

N2 - Background and aim: Altered gene expression in intestinal mucosa is thought to contribute to inflammatory process in Crohn’s disease (CD). The present study investigated changes in the expression of genes associated with gut inflammation in CD patients by RNA microarray to identify disease biomarkers. Methods: Microarray analysis was carried out in formalin-fixed, paraffin-embedded intestinal tissue specimens from six CD patients who underwent surgery without prior treatment and from two healthy control subjects. Transcripts overexpressed in CD patients were validated by enzyme-linked immunosorbent assay (ELISA) using specimens from 46 CD patients and 60 healthy controls. Results: Among the genes over-expressed with statistical significance, five genes including decay-accelerating factor, interleukin-1 receptor (IL1R) A, tumour necrosis factor receptor 2, (C-X-C motif) ligand (CXCL) 1, and granzyme (GZM) B proposed to have functional association with CD were selected to validate the expressed transcripts in serum. Serum concentration of IL1RA, CXCL1, and GZMB measured by ELISA were significantly higher in CD patients. Conclusions: We identified that IL1RA, CXCL1, and GZMB are overexpressed in CD patients. Serum IL1RA and GZMB levels were markedly increased in CD patients, suggesting that these markers can serve as biomarkers to identify gut inflammation. Further studies will be required to evaluate this possibility.

AB - Background and aim: Altered gene expression in intestinal mucosa is thought to contribute to inflammatory process in Crohn’s disease (CD). The present study investigated changes in the expression of genes associated with gut inflammation in CD patients by RNA microarray to identify disease biomarkers. Methods: Microarray analysis was carried out in formalin-fixed, paraffin-embedded intestinal tissue specimens from six CD patients who underwent surgery without prior treatment and from two healthy control subjects. Transcripts overexpressed in CD patients were validated by enzyme-linked immunosorbent assay (ELISA) using specimens from 46 CD patients and 60 healthy controls. Results: Among the genes over-expressed with statistical significance, five genes including decay-accelerating factor, interleukin-1 receptor (IL1R) A, tumour necrosis factor receptor 2, (C-X-C motif) ligand (CXCL) 1, and granzyme (GZM) B proposed to have functional association with CD were selected to validate the expressed transcripts in serum. Serum concentration of IL1RA, CXCL1, and GZMB measured by ELISA were significantly higher in CD patients. Conclusions: We identified that IL1RA, CXCL1, and GZMB are overexpressed in CD patients. Serum IL1RA and GZMB levels were markedly increased in CD patients, suggesting that these markers can serve as biomarkers to identify gut inflammation. Further studies will be required to evaluate this possibility.

KW - biomarker

KW - Crohn’s disease

KW - inflammatory bowel disease

KW - RNA microarray

KW - transcripts

UR - http://www.scopus.com/inward/record.url?scp=85031494740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031494740&partnerID=8YFLogxK

U2 - 10.1080/1354750X.2017.1387933

DO - 10.1080/1354750X.2017.1387933

M3 - Article

C2 - 28972805

AN - SCOPUS:85031494740

VL - 23

SP - 161

EP - 166

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 2

ER -